Welcome to the TRIlogy-5 Study
A study for people whose multiple myeloma is not responding to their
current medication(s) or has returned after they’ve received
at least 1 to 3 prior lines of therapy.
Welcome to the TRIlogy-5 Study
A study for people whose multiple myeloma is not responding to their
current medication(s) or has returned after they’ve received
at least 1 to 3 prior lines of therapy.
You may qualify to participate if you:
- Are 18 years of age or older
- Have been diagnosed with multiple myeloma
- Have received at least 1 to 3 prior myeloma therapies
There are other criteria that you will need to meet to qualify, including certain prior treatments, which the study doctor will discuss with you.
You CANNOT join the study if:
- You have cancer other than multiple myeloma
- You have had major surgery or a traumatic injury within 2 weeks before the first dose of the investigational medication
- You have a diagnosis of seizure, heart attack, or pulmonary embolism within 6 months prior to your first dose of study treatment
What to Expect as a Participant
The study is made up of the following parts:
Screening Phase |
|
Treatment Phase |
|
Follow-up Phase |
|
What to Expect as a Participant
The study is made up of the following parts:
Screening Phase |
|
Treatment Phase |
|
Follow-up Phase |
|
Clinical research studies help find better ways to treat different conditions. How well a study medication works and how safe it may be can depend on multiple factors, such as a person’s age, sex assigned at birth, and genetic background. It is important to include a wide range of backgrounds to help ensure that study medications are generally safe and effective for all patient populations.
See if you may qualify
Answer the following questions to see if you or someone you know may be eligible to take part in this study.
Please keep in mind: Even if you believe you meet the eligibility criteria, joining a clinical research study is not guaranteed. Whether you’re referred or able to take part depends on a review by a qualified healthcare professional.
Note about privacy: Email responses may not be encrypted. This means there’s a chance the messages could be seen by someone other than the intended recipient. We will avoid including sensitive personal information in emails whenever possible. However, we cannot guarantee that no sensitive information will be revealed indirectly.
About your information:
With your consent, we will use your answers to help determine whether you may be eligible for this clinical trial. You can withdraw your consent at any time.
Your information may be transferred to countries outside your country of residence, including the United States, which may have different data protection rules.
If you submit any personal information about someone else, you confirm that you have permission to do so.
Please read our Privacy policy for more details.